MIRO2 Gene

MIRO2 Gene

Overview

MIRO2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">MIRO2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>MIRO2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>MIRO2</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=MIRO2" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">11 edges</a></td>
</tr>
</table>

MIRO2 (also known as RHOT2) encodes mitochondrial Rho GTPase 2, an outer-mitochondrial-membrane trafficking regulator that integrates calcium sensing, motor-adaptor assembly, and organelle quality-control signaling.[@fransson2003][@saotome2008] In [neurons](/entities/neurons), this positioning function is not a housekeeping detail. It determines whether ATP-generating mitochondria reach synapses, whether damaged mitochondria are immobilized for quality control, and whether axons preserve energy homeostasis during stress.[@saotome2008][@oeding2023]

Although most mechanistic work has historically centered on [RHOT1](/genes/rhot1) (MIRO1), newer data indicate that RHOT2 contributes distinct control over mitochondrial motor-adaptor architecture and can modulate mitophagy readiness in stress states.[@oeding2023][@safiulina2019][@lopezdomenech2021] This is relevant to neurodegeneration, where mitochondrial trafficking failure, bioenergetic collapse, and defective organelle clearance converge across [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and [Huntington's disease](/diseases/huntingtons).[@lopezdomenech2021][@lin2016][@madadi2020]

The gene is therefore best interpreted as a network coordinator rather than a single-pathway factor: MIRO2 influences transport velocity, stopping behavior near calcium microdomains, and transition from transport to degradation programs through the [PINK1-Parkin mitophagy pathway](/mechanisms/pink1-parkin-mitophagy-pathway).[@safiulina2019][@wang2011]

Genomic Context And Protein Architecture

MIRO2 is located on chromosome 16 and encodes a tail-anchored outer-membrane GTPase.[@national2026] Its protein product, [MIRO2 Protein](/proteins/miro2-protein), shares core architecture with MIRO1:

• An N-terminal GTPase-like domain
• Two EF-hand calcium-binding motifs
• A C-terminal GTPase-like domain
• A transmembrane anchor inserting the protein into the mitochondrial outer membrane[@fransson2003][@saotome2008]

Physiologic Function In Neurons

Mitochondrial Positioning For Synaptic Demand

Neurons depend on long-range trafficking to deliver mitochondria to presynaptic terminals, [dendritic spines](/mechanisms/dendritic-spines), and axon initial segments. MIRO proteins couple mitochondria to motor-adaptor complexes and thereby enable bidirectional trafficking along microtubules.[@saotome2008][@lopezdomenech2018] This function is tightly tied to synaptic performance because local ATP production and calcium buffering are location dependent.

Calcium-Gated Motility Control

When local calcium rises, MIRO-dependent transport is reprogrammed so mitochondria pause near active compartments. This stop-and-go behavior helps maintain calcium homeostasis and protects from local excitotoxic stress.[@saotome2008][@stephen2049] In disease-relevant settings, failure of this gating can produce either pathologic stalling (insufficient distribution) or pathologic persistence of movement (failure to stabilize near high-demand domains).

Interface With Quality Control

A key transition in mitochondrial biology is the shift from motility to quality control. MIRO proteins are central to this transition. Upon mitochondrial damage, PINK1/Parkin signaling marks MIRO for removal, arresting motility and allowing damaged organelles to enter [mitophagy](/mechanisms/mitophagy).[@wang2011][@cai2012] This step prevents continued trafficking of dysfunctional mitochondria into synaptic compartments.

Mechanistic Role In Neurodegeneration

Transport Failure As An Early Lesion

Across major neurodegenerative disorders, transport defects often precede overt cell death. Disturbed MIRO-regulated transport can reduce mitochondrial density at synapses, worsen ATP shortfall, and amplify calcium dysregulation.[@lopezdomenech2021][@lin2016] In cortical and striatal systems, this creates vulnerability in neurons with long projections and high firing burden.

Mitophagy Coupling Defects

If MIRO-dependent motility arrest does not occur efficiently during mitochondrial injury, damaged organelles can evade quality-control checkpoints. Experimental systems show that Miro proteins prime mitochondria for Parkin translocation and influence mitophagic competence.[@safiulina2019] This has direct relevance to PD-linked pathways where mitochondrial turnover is already strained.[@wang2011]

Integrated Stress Response Convergence

Loss-of-function and dysregulation studies in the Miro axis have also been linked to maladaptive stress signaling and neuronal dysfunction, including integrated-stress-response amplification in some contexts.[@lopezdomenech2021] This supports a model in which MIRO2 perturbation is not purely structural; it can alter downstream proteostasis and translational control modules.

Disease-Focused Interpretation

Parkinson's Disease

The strongest mechanistic bridge is in PD-related mitochondrial quality control. PINK1/Parkin signaling targets Miro-family proteins to halt damaged mitochondrial transport, a prerequisite for effective mitophagy.[@wang2011][@cai2012] If this checkpoint is inefficient, dopaminergic neurons in metabolically demanding circuits may accumulate dysfunctional mitochondria, increasing oxidative and bioenergetic stress.[@lopezdomenech2021][@lin2016]

MIRO2 should therefore be viewed as a modifier of mitophagy efficiency rather than a classic monogenic PD driver. Even without frequent high-penetrance variants, pathway-level dysregulation may influence disease tempo or therapeutic response.

Alzheimer's Disease

AD models consistently show impaired mitochondrial trafficking, synaptic energy failure, and calcium imbalance. MIRO-dependent transport logic intersects with each of these abnormalities.[@lin2016][@stephen2049] Emerging systems work suggests that mitochondrial motility regulators can shape dendritic maintenance and white-matter resilience after injury, supporting translational relevance beyond one diagnosis.[@galloway2020][@qin2019]

Huntington's Disease And Related Corticostriatal Disorders

HD features early corticostriatal energy stress and transport disruption. The Miro axis provides a mechanistic link between cytoskeletal transport and mitochondrial competency in these vulnerable neurons.[@lin2016][@burel2016] In this framing, MIRO2 is part of the broader vulnerability architecture that determines whether high-demand projection neurons compensate or decompensate under proteotoxic and metabolic burden.

Translational And Biomarker Considerations

Why MIRO2 Is A Practical Translational Node

MIRO2 sits at a measurable interface: transport phenotypes, mitophagy state transitions, and stress-response outputs can be quantified in iPSC-derived neurons and high-content imaging pipelines.[@oeding2023][@lopezdomenech2021] This makes MIRO2 a useful experimental readout for candidate interventions targeting mitochondrial resilience.

Candidate Readouts

• Mitochondrial velocity, run length, and directional bias in axons/dendrites
• Calcium-dependent stopping behavior under physiologic stimulation
• Parkin recruitment kinetics after mitochondrial depolarization
• Mitophagic flux metrics linked to transport arrest competence[@safiulina2019][@wang2011]

Therapeutic Hypothesis Space

Current evidence supports testing MIRO2-centered hypotheses indirectly through pathway-directed strategies:

• Agents improving mitochondrial quality control in PD-relevant systems
• Interventions reducing maladaptive stress signaling during trafficking defects
• Combination approaches pairing transport-rescue and mitophagy-enhancement mechanisms[@safiulina2019][@lopezdomenech2021][@wang2011]

Research Priorities

See Also

• [MIRO2 Protein](/proteins/miro2-protein)
• [RHOT1](/genes/rhot1)
• [Mitophagy](/mechanisms/mitophagy)
• [PINK1-Parkin Mitophagy Pathway in Parkinson's Disease](/mechanisms/pink1-parkin-mitophagy-pathway)
• [Axonal Transport](/mechanisms/axonal-transport)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: miro2](https://www.ncbi.nlm.nih.gov/gene/)
• [PubMed: miro2](https://pubmed.ncbi.nlm.nih.gov/?term=miro2+neurodegeneration)

References